BHUBANESWAR, India, March 30, 2025 /PRNewswire/ -- KIIT Deemed to be University (https://kiit.ac.in/), Bhubaneswar, India, continues to expand its global footprint through strategic partnerships with reputed international institutions. It has recently signed Memoranda of Understanding (MoUs) with three prestigious universities - the University of Tulsa (USA), Toi Ohomai Institute of Technology (New Zealand), and the University of Washington-Bothell (USA). These collaborations offer students and faculty enhanced academic and research opportunities.
As part of its global education initiative, KIIT has partnered with the University of Tulsa, Oklahoma, USA, to launch a dual degree program in B.Tech. This 2+2 model allows students to complete two years at KIIT and the remaining two years at the University of Tulsa, earning a degree from both institutions.
Beyond the dual degree program, 40 KIIT students from various disciplines, including engineering and liberal studies, will participate in short-term courses at the University of Tulsa, gaining hands-on experience and international exposure. This partnership also facilitates faculty exchanges, joint research projects, and sabbatical opportunities between the two institutions.
Further strengthening its international presence, KIIT has signed an MoU with Toi Ohomai Institute of Technology, New Zealand. Signed in the presence of Mr. Christopher Luxon, Hon'ble Prime Minister of New Zealand, the partnership aims to enhance teaching and research capabilities, focusing on articulation pathways in commerce and management at both undergraduate and postgraduate levels. Toi Ohomai is a leading vocational and applied tertiary education provider known for its industry-aligned programs and hands-on learning approach.
KIIT has also forged an impactful academic collaboration with the University of Washington-Bothell (UWB), USA, through an immersive learning initiative. A delegation of 18 members from UWB, during their visit to KIIT, worked with KIIT's management students to analyze real-world business challenges faced by local enterprises and develop sustainable solutions.
This initiative brought together students from both universities, providing them with valuable international exposure and practical learning experiences. The collaboration represents an innovative model for global academic engagement, encouraging universities to move beyond traditional exchange programs and embrace collaborative teaching models.
With over 350 MoUs signed with leading universities and corporations worldwide, KIIT has established itself as a hub for academic excellence and cultural exchange. Dr. Achyuta Samanta, Founder, KIIT, KISS & KIMS, emphasized the importance of such collaborations in equipping students with a global perspective, AI integration, and skill development opportunities that align with the evolving global workforce.
BHUBANESWAR, India, March 30, 2025 /PRNewswire/ -- KIIT Deemed to be University (https://kiit.ac.in/), Bhubaneswar, India, continues to expand its global footprint through strategic partnerships with reputed international institutions. It has recently signed Memoranda of Understanding (MoUs) with three prestigious universities - the University of Tulsa (USA), Toi Ohomai Institute of Technology (New Zealand), and the University of Washington-Bothell (USA). These collaborations offer students and faculty enhanced academic and research opportunities.
As part of its global education initiative, KIIT has partnered with the University of Tulsa, Oklahoma, USA, to launch a dual degree program in B.Tech. This 2+2 model allows students to complete two years at KIIT and the remaining two years at the University of Tulsa, earning a degree from both institutions.
Beyond the dual degree program, 40 KIIT students from various disciplines, including engineering and liberal studies, will participate in short-term courses at the University of Tulsa, gaining hands-on experience and international exposure. This partnership also facilitates faculty exchanges, joint research projects, and sabbatical opportunities between the two institutions.
Further strengthening its international presence, KIIT has signed an MoU with Toi Ohomai Institute of Technology, New Zealand. Signed in the presence of Mr. Christopher Luxon, Hon'ble Prime Minister of New Zealand, the partnership aims to enhance teaching and research capabilities, focusing on articulation pathways in commerce and management at both undergraduate and postgraduate levels. Toi Ohomai is a leading vocational and applied tertiary education provider known for its industry-aligned programs and hands-on learning approach.
KIIT has also forged an impactful academic collaboration with the University of Washington-Bothell (UWB), USA, through an immersive learning initiative. A delegation of 18 members from UWB, during their visit to KIIT, worked with KIIT's management students to analyze real-world business challenges faced by local enterprises and develop sustainable solutions.
This initiative brought together students from both universities, providing them with valuable international exposure and practical learning experiences. The collaboration represents an innovative model for global academic engagement, encouraging universities to move beyond traditional exchange programs and embrace collaborative teaching models.
With over 350 MoUs signed with leading universities and corporations worldwide, KIIT has established itself as a hub for academic excellence and cultural exchange. Dr. Achyuta Samanta, Founder, KIIT, KISS & KIMS, emphasized the importance of such collaborations in equipping students with a global perspective, AI integration, and skill development opportunities that align with the evolving global workforce.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc. Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
